Chagas' Heart Disease

Evidence-Based Cardiology: Third Edition

Volumn , Issue , 2010, Pages 823-841

  Marin Neto, J Antonio ^a   Rassi, Anis ^b   Carlos Maciel, Benedito ^a   Vinicius Simões, Marcus ^a   Schmidt, André ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Anis Rassi Hospital   (Brazil)

Author keywords

Chagas' heart disease; Clinical features highly variable clinical expression; Epidemiology vectoral transmission through feces of infected insects; Etiologic treatment identification of potential targets for chemotherapy; Natural history and prognostic factors acute organ damage; Pathophysiology and pathogenetic mechanisms lymphadenopathy; Prevention measures aimed at minimizing medical and social burden

Indexed keywords

EID: 77950814688     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444309768.ch51     Document Type: Chapter

References (140)

1. Chagas C. Über eine neue Trypanosomiasis des Menschen. Band XIII 1909; 5-7.
2. Chagas C, Vilella E. Cardiac form of American trypanosomiasis . Mem Inst Oswaldo Cruz 1922; 14: 5-61.
3. Laranja FS, Dias E, Nobrega G, Miranda A. Chagas' disease: a clinical, epidemiologic and pathologic study. Circulation 1956; 14: 1035-59.
4. Prata A. Clinical and epidemiological aspects of Chagas' disease. Lancet Infect Dis 2001; 1: 92-100.
5. Rassi A Jr, Rassi A, Little WC. Chagas' heart disease. Clin Cardiol 2000; 23: 883-9.
6. Dias JCP. The indeterminate form of human chronic Chagas' disease: a clinical epidemiological review. Rev Soc Bras Med Trop 1989; 22: 147-56.
7. First Annual Meeting of Applied Research in Chagas' Disease. Araxá MG. 1984. Rev Soc Bras Med Trop 1985; 18: 46.
8. Barreto ACP, Ianni BM. The undetermined form of Chagas' heart disease: concept and forensic implications. São Paulo Med J 1995; 13: 797-801.
9. Barreto ACP, Arteaga-Fernandez E. RV endomyocardial biopsy in chronic Chagas' disease. Am Heart J 1986; 111: 307-12.
10. Marin-Neto JA, Bromberg-Marin G, Pazin-Filho A, Simões MV, Maciel BC. Cardiac autonomic impairment and early myocardial damage involving the right ventricle are independent phenomena in Chagas' disease Int J Cardiol 1998; 65: 261-9.
11. Almeida-Filho OC, Maciel BC, Schmidt A, Pazin-Filho A, Marin-Neto JA. Minor segmental dyssynergy reflects extensive myocardial damage and global left ventricle dysfunction in chronic Chagas disease. J Am Soc Echocardiogr 2002; 156: 610-16.
12. Pazin-Filho A, Romano MM, Almeida-Filho OC et al. Minor segmental wall motion abnormalities detected in patients with Chagas' disease have adverse prognostic implications. Braz J Med Biol Res 2006; 394: 483-7.
13. Marin-Neto JA, Almeida Filho OC, Pazin-Filho A, Maciel BC. [Indeterminate form of Chagas' disease. Proposal of new diagnostic criteria and perspectives for early treatment of cardiomyopathy] myopathy]. A rq Bras Cardiol 2002; 796: 623-7.
14. Bern C, Montgomery SP, Herwaldt BL et al. Evaluation and treatment of Chagas disease in the United States: a systematic review. JAMA 2007; 29818: 2171-81.
15. Kirchhoff LV. Changing epidemiology and approaches to therapy for Chagas disease. Curr Infect Dis Rep 2003; 51: 59-65.
16. Organizacion Panamericana de la Salud. Estimacion cuantitativa de la enfermedad de Chagas en las Americas. Montevideo, Uruguay: Organizacion Panamericana de la Salud, 2006: 425-506.
17. Moncayo A, Ortiz Yanine MI. An update on Chagas disease human American trypanosomiasis. Ann Trop Med Parasitol 2006; 1008: 663-77.
18. Control of Chagas disease. World Health Organ Tech Rep Ser 2002; 905:i-109.
19. Coura JR, Junqueira AC, Fernandes O, Valente SA, Miles MA. Emerging Chagas disease in Amazonian Brazil. Trends Parasitol 2002; 184: 171-6.
20. Hagar JM, Rahimtoola SH. Chagas' heart disease. Curr Probl Cardiol 1995; 2012: 825-924.
21. Leiby DA, Read EJ, Lenes BA et al. Seroepidemiology of Trypanosoma cruzi, etiologic agent of Chagas' disease, in US blood donors. J Infect Dis 1997; 1764: 1047-52.
22. Garraud O, Andreu G, Elghouzzi MH, Laperche S, Lefrere JJ. Measures to prevent transfusion-associated protozoal infections in non-endemic countries. Travel Med Infect Dis 2007; 52: 110-12.
23. Herwaldt BL, Grijalva MJ, Newsome AL et al. Use of polymerase chain reaction to diagnose the fifth reported US case of autochthonous transmission of Trypanosoma cruzi, in Tennessee, 1998. J Infect Dis 2000; 1811: 395-9.
24. Blood donor screening for chagas disease-United States, 2006-2007. MMWR 2007; 567: 141-3.
25. Dias JC, Silveira AC, Schofield CJ. The impact of Chagas disease control in Latin America: a review. Mem Inst Oswaldo Cruz 2002; 975: 603-12.
26. Morel CM, Lazdins J. Chagas disease. Nat Rev Microbiol 2003; 11: 14-15.
27. Miles MA, Cedillos RA, Povoa MM, de Souza AA, Prata A, Macedo V. Do radically dissimilar Trypanosoma cruzi strains zymodemes. cause Venezuelan and Brazilian forms of Chagas' disease. Lancet 1981; 8234: 1338-40.
28. Rassi A Jr, Rassi A, Rassi SG. Predictors of mortality in chronic Chagas disease: a systematic review of observational studies. Circulation 2007; 1159: 1101-8.
29. Dias JCP. Cardiopatia chagásica: história natural. In: Cançado JR, Chuster M (eds) Cardiopatia Chagásica. Belo Horizonte: Fundação Carlos Chagas de Pesquisa Médica, 1985.
30. Rassi A, Rassi A Jr, Rassi GG. Fase aguda. In: Brener Z, Andrade ZA, Barral-Netto M (eds) Trypanosoma cruzie Doença de Chagas. Rio de Janeiro: Guanabara Koogan SA, 2000.
31. Benchimol Barbosa PR. The oral transmission of Chagas' disease: an acute form of infection responsible for regional outbreaks . Int J Cardiol 2006; 1121: 132-3.
32. Forichon E. Contribution aux Estimations de Morbiditéet de Mortalitédans la Maladie de Chagas. Toulouse: Universiter Paul-Sabatier, 1974.
33. Puigbó JJ, Rhode JRN, Barrios HG, Yépez CG. A 4-year follow up study of a rural community with endemic Chagas' disease. Bull WHO 1968; 39: 341-8.
34. Mota EA, Guimaraes AC, Santana OO, Sherlock I, Hoff R, Weller TH. A nine year prospective study of Chagas' disease in a defined rural population in northeast Brazil. Am J Trop Med Hyg 1990; 425: 429-40.
35. Ianni BM, Arteaga E, Frimm CC, Pereira Barretto AC, Mady C. Chagas' heart disease: evolutive evaluation of electrocardiographic and echocardiographic parameters in patients with the indeterminate form. Arq Bras Cardiol 2001; 771: 59-62.
36. Viotti R, Vigliano C, Lococo B et al. [Clinical predictors of chronic chagasic myocarditis progression]. Rev Esp Cardiol 2005; 589: 1037-44.
37. Manzullo EC, Chuit R. Risk of death due to chronic chagasic cardiopathy. Mem Inst Oswaldo Cruz 1999; 94 (suppl 1): 317-20.
38. Maguire JH, Hoff R, Sherlock I et al. Cardiac morbidity and mortality due to Chagas' disease: prospective electrocardiographic study of a Brazilian community. Circulation 1987; 756: 1140-5.
39. Espinosa R, Carrasco HA, Belandria F et al. Life expectancy analysis in patients with Chagas' disease: prognosis after one decade 1973-1983. I nt J Cardiol 1985; 81: 45-56.
40. Pugliese C, Lessa I, Santos FA. [Survival of decompensated chronic Chagas' myocardiopathy]. Rev Inst Med Trop Sao Paulo 1976; 183: 191-201.
41. Mady C, Cardoso RH, Barretto AC, da Luz PL, Bellotti G, Pileggi F. Survival and predictors of survival in patients with congestive heart failure due to Chagas' cardiomyopathy. Circulation 1994; 906: 3098-102.
42. Hagar JM, Rahimtoola SH. Chagas' heart disease in the United States. N Engl J Med 1991; 3251: 763-8.
43. de Paola AA, Gomes JA, Terzian AB, Miyamoto MH, Martinez Fo EE. Ventricular tachycardia during exercise testing as a predictor of sudden death in patients with chronic chagasic cardiomyopathy and ventricular arrhythmias. Br Heart J 1995; 743: 293-5.
44. Rassi A Jr, Rassi A, Little WC et al. Development and validation of a risk score for predicting death in Chagas' heart disease. N Engl J Med 2006; 3558: 799-808.
45. Marin-Neto JA, Cunha-Neto E, Maciel BC, Simoes MV. Pathogenesis of chronic Chagas heart disease. Circulation 2007; 1159: 1109-23.
46. Higuchi ML. Chronic chagasic cardiopathy: the product of a turbulent host-parasite relationship. Rev Inst Med Trop São Paulo 1997; 39: 53-60.
47. Köberle F. Chagas' heart disease and Chagas' syndromes: the pathology of American trypanosomiasis. Adv Parasitol 1968; 6: 63-116.
48. Lopes ER, Tafuri WL. Involvement of the autonomic nervous system in Chagas' heart disease. Rev Soc Bras Med Trop 1983; 16: 206-11.
49. Amorim DS, Manço JC, Gallo L Jr, Marin-Neto JA. Chagas' heart disease as an experimental model for studies of cardiac autonomic function in man. Mayo Clin Proc 1982; 57: 48-60.
50. Marin-Neto JA, Maciel BC, Gallo L Jr, Junqueira LF Jr, Amorim DS. Effect of parasympathetic impairment on the hemodynamic response to handgrip in Chagas' heart disease. Br Heart J 1986; 55: 204-8.
51. Amorim DS, Marin-Neto JA. Functional alterations of the autonomic nervous system in Chagas' heart disease. São Paulo Med J 1995; 113: 772-84.
52. Simões MV, Pintya AO, Bromberg-Marin G et al. Relation of regional sympathetic denervation and myocardial perfusion disturbances to wall motion impairment in Chagas' cardiomyopathy . Am J Cardiol 2000; 869: 975-81.
53. Oliveira JSM. A natural human model of intrinsic heart nervous system denervation: Chagas' cardiopathy. Mem Inst Oswaldo Cruz 1996; 91: 2117-24.
54. Rossi MA, Carobrez SG. Experimental Trypanosoma cruzi cardiomyopathy in BALB/c mice: histochemical evidence of hypoxic changes in the myocardium. Br J Exp Pathol 1985; 662: 155-60.
55. Factor SM, Cho S, Wittner M, Tanowitz H. Abnormalities of the coronary microcirculation in acute murine Chagas' disease. Am J Trop Med Hyg 1985; 342: 246-53.
56. Morris SA, Weiss LM, Factor SM, Bilezikian JP, Tanowitz HB, Wittner M. Verapamil ameliorates clinical, pathological and biochemical manifestations of the experimental chagasic cardiomyopathy in mice. J Am Coll Cardiol 1989; 14: 782-9.
57. Ferrans VJ, Milei J, Tomita Y, Storino RA. Basement membrane thickening in cardiac myocytes and capillaries in chronic Chagas' disease. A m J Cardiol 1988; 6113: 1137-40.
58. Morris SA, Tanowitz HB, Wittner M, Bilezikian JP. Pathophysiological insights into the cardiomyopathy of Chagas' disease. Circulation 1990; 826: 1900-9.
59. Rossi MA. Microvascular changes as a cause of chronic cardiomyopathy in Chagas' disease. Am Heart J 1990; 120: 233-6.
60. Marin-Neto JA, Marzullo P, Marcassa C et al. Myocardial perfusion abnormalities in chronic Chagas' disease. Assessment with thallium-201 scintigraphy. A m J Cardiol 1992; 69: 780-4.
61. Hiss FC, Lascala TF, Maciel BC, Marin-Neto JA, Simões MV. Changes in myocardial perfusion correlate with deterioration of left ventricular systolic function in chronic Chagas' cardiomyopathy . Am Coll Cardiol Img 2009; 2: 164-72.
62. Andrade ZA, Andrade SG, Sadigursky M et al. The indeterminate phase of Chagas' disease: ultrastructural characterization of cardiac changes in the canine model. Am J Trop Med Hyg 1997; 57: 328-36.
63. Lopes ER, Chapadeiro E, Andrade ZA, Almeida HO, Rocha A. [Pathological anatomy of hearts from asymptomatic Chagas disease patients dying in a violent manner]. Mem Inst Oswaldo Cruz 1981; 762: 189-97.
64. Carrasco-Guerra HA, Palacios-Pru E, Dagert de Scorza C et al. Clinical histochemical and ultrastructural correlation in septal endomyocardial biopsies from chronic chagasic patients. Am Heart J 1987; 113; 716-24.
65. Ben Younes-Chennoufi A, Hontebeyrie-Joskowicz M, Tricottet V et al. Persistence of Trypanosoma cruzi antigens in the inflammatory lesions of chronically infected mice. Trans Roy Soc Trop Med Hyg 1988; 82: 77-83.
66. Franco MF. Experimental carditis induced by Trypanosoma cruzi strain in guinea pigs: correlation between histopathology and the presence of T. cruzi antigens identified by indirect immunofluorescence. Rev Soc Bras Med 1990; 3: 187-9.
67. Higuchi ML, Brito T, Reis MM et al. Correlation between T. cruzi parasitism and myocardial inflammation in human chronic chagasic myocarditis: light microscopy and immunohistochemical findigns. Cardiovasc Pathol 1993; 2: 101-6.
68. Bellotti G, Bocchi EA, de Moraes AV et al. In vivo detection of Trypanosoma cruzi antigens in hearts of patients with chronic Chagas' heart disease. Am Heart J 1996; 1312: 301-7.
69. Jones EM, Colley DG, Tostes S, Lopes ER, Vnencak-Jones CL, McCurley TL. Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy . Am J Trop Med Hyg 1993; 483: 348-57.
70. Añez N, Carrasco H, Parada H et al. Myocardial parasite persistence in chronic chagasic patients. Am J Trop Med Hyg 1999; 60: 726-32.
71. Andrade SG, Stocker-Guerret S, Pimentel AS, Grimaud JA. Reversibility of cardiac fibrosis in mice chronically infected with Trypanosoma cruzi, under specific chemotherapy. Mem Inst Oswaldo Cruz 1991; 862: 187-200.
72. Garcia S, Ramos CO, Senra JFV et al. Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations. Antimicrob Agents Chemother 2005; 49: 1521-8.
73. Andrade ZA, Andrade SG, Sadigursky M. Enhancement of chronic Trypanosoma cruzi myocarditis in dogs treated with low doses of cyclophosphamide. Am J Pathol 1987; 1273: 467-73.
74. Silva JS, Rossi MA. Intensification of acute Trypanosoma cruzi myocarditis in BALB/c mice pretreated with low doses of cyclophosphamide or gamma irradiation. J Exp Pathol Oxford 1990; 711: 33-9.
75. Okumura M, Mester M, Iriya K, Amato N, V, Gama-Rodrigues J. Effects of immunosuppression and benzonidazole on Trypanosoma cruzi parasitism during experimental acute Chagas' disease. Transplant Proc 1994; 263: 1587-9.
76. Bocchi EA, Bellotti G, Mocelin AO et al. Heart transplantation for chronic Chagas' heart disease. Ann Thorac Surg 1996; 616: 1727-33.
77. Harms G, Feldmeier H. The impact of HIV infection on tropical diseases. I nfect Dis Clin North Am 2005; 191: 121-35, ix.
78. Rassi A, Amato N, de Siqueira AF et al. [The influence of corticoids, in Chronic Chagas disease, administered in virtue of associated disorders]. Rev Soc Bras Med Trop 1997; 302: 93-9.
79. Simoes MV, Soares FA, Marin-Neto JA. Severe myocarditis and esophagitis during reversible long standing Chagas' disease recrudescence in immunocompromised host. Int J Cardiol 1995; 493: 271-3.
80. Andrade ZA. Immunopathology of Chagas disease. Mem Inst Oswaldo Cruz 1999; 94 (suppl 1): 71-80.
81. Higuchi MD, Gutierrez PS, Aiello VD et al. Immunohistochemical characterization of infiltrating cells in human chronic chagasic myocarditis: comparison with myocardial rejection process. Virchows Arch A Pathol Anat Histopathol 1993; 423: 157-60.
82. Cunha-Neto E, Bilate AM, Hyland KV, Fonseca SG, Kalil J, Engman DM. Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry. Autoimmunity 2006; 391: 41-54.
83. Simoes MV, Nonino A, Simoes BP, Almeida-Filho OC, Maciel BC, Marin-Neto JA. [Reagudization of Chagas myocarditis inducing exclusive right ventricular failure]. Arq Bras Cardiol 1994; 626: 435-7.
84. Gallo L Jr, Marin-Neto JA, Manço JC, Rassi A, Amorim DS. Abnormal heart rate responses during exercise in patients with Chagas' disease. C ardiology 1975; 60: 147-62.
85. Simoes MV, Dantas RO, Ejima FH, Meneghelli UG, Maciel BC, Marin-Neto JA. [Esophageal origin of precordial pain in chagasic patients with normal subepicardial coronary arteries]. Arq Bras Cardiol 1995; 642: 103-8.
86. Marin-Neto JA, Simões MV, Ayres-Neto EM et al. Studies of the coronary circulation in Chagas' heart disease. São Paulo Med J 1995; 113: 826-34.
87. Maciel BC, Almeida Filho OC, Schmidt A, Marin-Neto JA. Ventricular function in Chagas' heart disease. Sao Paulo Med J 1995; 1132: 814-20.
88. Rassi JA, Gabriel RA, Gabriel RS, Rassi JL, Rassi A. [Ventricular arrhythmia in Chagas disease. Diagnostic, prognostic, and therapeutic features]. Arq Bras Cardiol 1995; 654: 377-87.
89. Oliveira JSM, Araújo RRC, Mucillo G. Cardiac thrombosis and thromboembolism in chronic Chagas' heart disease. Am J Cardiol 1983; 52: 147-51.
90. Oliveira JS, Mello De Oliveira JA, Frederigue U Jr, Lima Filho EC. Apical aneurysm of Chagas' s heart disease. Br Heart J 1981; 464: 432-7.
91. Marin-Neto JA, Andrade ZA. [Why is there predominance of right heart failure in Chagas' disease?] Arq Bras Cardiol 1991; 573: 181-3.
92. Prata A, Andrade Z, Guimarães AC. Chagas' heart disease. In: Shaper AG, Hutt MSR, Fejfar Z (eds) Cardiovascular Disease in the Tropics. London: British Medical Association, 1974.
93. Marin-Neto JA, Sousa AC, Maciel BC, Gallo JL, Iazigi N. [Radionuclide angiocardiographic evaluation of the effect of isosorbide dinitrate in patients with Chagas' disease]. Arq Bras Cardiol 1988; 515: 367-71.
94. Rassi A Jr, Rassi SG, Rassi A. Sudden death in Chagas' disease. Arq Bras Cardiol 2001; 76: 75-96.
95. Lopes ER. Sudden death in patients with Chagas disease. Mem Inst Oswaldo Cruz 1999; 94 (suppl 1): 321-4.
96. Ribeiro AL, Moraes RS, Ribeiro JP et al. Parasympathetic dysautonomia precedes left ventricular systolic dysfunction in Chagas disease. Am Heart J 2001; 1412: 260-5.
97. Consolim-Colombo FM, Filho JA, Lopes HF et al. Decreased cardiopulmonary baroreflex sensitivity in Chagas' heart disease. Hypertension 2000; 366: 1035-9.
98. Soares Barreto-Filho JA, Consolim-Colombo FM, Ferreira LH, Martins Sobrinho CR, Guerra-Riccio GM, Krieger EM. Dysregulation of peripheral and central chemoreflex responses in Chagas' heart disease patients without heart failure. Circulation 2001; 1041: 1792-8.
99. Docampo R. Recent developments in the chemotherapy of Chagas disease. Curr Pharm Des 2001; 712: 1157-64.
100. Rassi A, Ferreira HO. Tentativas de tratamento especifico da fase aguda da doenca de Chagas com nifurtimox em esquema de duracao prolongada. Rev Soc Bras Med Trop 1971; 5: 235-62.
101. Borges-Pereira J, Junqueira AC, Santos LC, de Castro JA, de Araujo IB, Coura JR. [Xenodiagnosis in chronic Chagas' disease. I. The sensitivity of Panstrongylus megistus and Triatoma infestans]. R ev Soc Bras Med Trop 1996; 294: 341-7.
102. Britto C, Cardoso MA, Ravel C et al. Trypanosoma cruzi: parasite detection and strain discrimination in chronic chagasic patients from northeastern Brazil using PCR amplification of kinetoplast DNA and nonradioactive hybridization. Exp Parasitol 1995; 814: 462-71.
103. Rassi A, Luquetti AO. Specific treatment for Trypanosoma cruzi infection Chagas disease. In: Tyler KM, Miles MA (eds) American Trypanosomiasis. Boston: Kluwer Academic Publishers, 2003: 117-25.
104. Sartori AM, Ibrahim KY, Nunes Westphalen EV et al. Manifestations of Chagas disease American trypanosomiasis in patients with HIV/AIDS. Ann Trop Med Parasitol 2007; 1011: 31-50.
105. Fiorelli AI, Stolf NA, Honorato R et al. Later evolution after cardiac transplantation in Chagas' disease. Transplant Proc 2005; 376: 2793-8.
106. Maldonado C, Albano S, Vettorazzi L et al. Using polymerase chain reaction in early diagnosis of re-activated Trypanosoma cruzi infection after heart transplantation. J Heart Lung Transplant 2004; 2312: 1345-8.
107. Rassi A, Amato N, V, de Siqueira AF, Ferriolli FF, Amato VS, Rassi JA. [Protective effect of benznidazole against parasite reactivation in patients chronically infected with Trypanosoma cruzi and treated with corticoids for associated diseases]. Rev Soc Bras Med Trop 1999; 325: 475-82.
108. Riarte A, Luna C, Sabatiello R et al. Chagas' disease in patients with kidney transplants: 7 years of experience 1989-1996. Clin Infect Dis 1999; 293: 561-7.
109. Viotti R, Vigliano C, Armenti H, Segura E. Treatment of chronic Chagas' disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up. Am Heart J 1994; 1271: 151-62.
110. Viotti R, Vigliano C, Lococo B et al. Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial. Ann Intern Med 2006; 14410: 724-34.
111. Villar JC. Desenlaces clínicos de sujetos con infección crónica por Trypanosoma cruzi tratados o no con agentes tripanocidas. Un metaan álisis de estudios observacionales. MEDUNAB 2002; 5: 166-173.
112. Villar JC, Villar LA, Marin-Neto JA, Ebrahim S, Yusuf S. Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection. Cochrane Database of Systematic Reviews 2002, Issue 1. Art. No.: CD003463. DOI: 10.1002/14651858. CD003463.
113. Solari A, Ortiz S, Soto A et al. Treatment of Trypanosoma cruzi- infected children with nifurtimox: a 3 year follow-up by PCR. J Antimicrob Chemother 2001; 484: 515-19.
114. WHO Expert Committee. Control of Chagas Disease. WHO technical report series number 905. Geneva: World Health Organization, 2002.
115. Sosa-Estani S, Segura EL. Treatment of Trypanosoma cruzi infection in the undetermined phase. Experience and current guidelines of treatment in Argentina. Mem Inst Oswaldo Cruz 1999; 94: 363-5.
116. Mendoza I, Camardo J, Moleiro F et al. Sustained ventricular tachycardia in chronic chagasic myocarditis: electrophysiologic and pharmacologic characteristics. Am J Cardiol 1986; 576: 423-7.
117. Sosa E, Scanavacca M, d'Avila A et al. Endocardial and epicardial ablation guided by nonsurgical transthoracic epicardial mapping to treat recurrent ventricular tachycardia. J Cardiovasc Electrophysiol 1998; 93: 229-39.
118. d'Avila A, Splinter R, Svenson RH et al. New perspectives on catheter-based ablation of ventricular tachycardia complicating Chagas' disease: experimental evidence of the efficacy of near infrared lasers for catheter ablation of Chagas' VT. J Interv Card Electrophysiol 2002; 71: 23-38.
119. Scanavacca MI, Brito FS, Maia I. Diretrizes para avaliaçãoe tratamento de pacientes com arritmias cardíacas. Arq Bras Cardiol 2002; 79 (suppl):V 1-50.
120. Giniger AG, Retyk EO, Laino RA, Sananes EG, Lapuente AR. Ventricular tachycardia in Chagas' disease. Am J Cardiol 1992; 704: 459-62.
121. Leite LR, Fenelon G, Simoes A Jr, Silva GG, Friedman PA, de Paola AA. Clinical usefulness of electrophysiologic testing in patients with ventricular tachycardia and chronic chagasic cardiomyopathy treated with amiodarone or sotalol. J Cardiovasc Electrophysiol 2003; 146: 567-73.
122. Dubner S, Valero E, Pesce R et al. A Latin American registry of implantable cardioverter defibrillators: the ICD-LABOR study. Ann Noninvasive Electrocardiol 2005; 104: 420-8.
123. Rassi A Jr. Implantable cardioverter-defibrillators in patients with Chagas heart disease: misperceptions, many questions and the urgent need for a randomized clinical trial. J Cardiovasc Electrophysiol 2007; 18 (12): 1241-3.
124. Milei J, Pesce R, Valero E, Muratore C, Beigelman R, Ferrans VJ. Electrophysiologic-structural correlations in chagasic aneurysms causing malignant arrhythmias. Int J Cardiol 1991; 321: 65-73.
125. de Paola AA, Gomes JA, Miyamoto MH, Fo EE. Transcoronary chemical ablation of ventricular tachycardia in chronic chagasic myocarditis. J Am Coll Cardiol 1992; 202: 480-2.
126. Sosa E, Scanavacca M, d'Avila A, Bellotti G, Pilleggi F. Radiofrequency catheter ablation of ventricular tachycardia guided by nonsurgical epicardial mapping in chronic Chagasic heart disease. Pacing Clin Electrophysiol 1999; 221 (Pt 1): 128-30.
127. Batlouni M, Barretto AC, Armaganijan D et al. [Treatment of mild and moderate cardiac failure with captopril. A multicenter study]. Arq Bras Cardiol 1992; 585: 417-21.
128. Roberti RR, Martinez EE, Andrade JL et al. Chagas cardiomyopathy and captopril. Eur Heart J 1992; 137: 966-70.
129. Botoni FA, Poole-Wilson PA, Ribeiro AL et al. A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathy. Am Heart J 2007; 1534: 544-8.
130. Quiros FR, Morillo CA, Casas JP, Cubillos LA, Silva FA. CHARITY: Chagas cardiomyopathy bisoprolol intervention study: a randomized double-blind placebo force-titration controlled study with Bisoprolol in patients with chronic heart failure secondary to Chagas cardiomyopathy [NCT00323973 ]. Trials 2006; 7: 21.
131. Buffolo E, Branco JN, Catani R. End-stage cardiomyopathy and secondary mitral insufficiency surgical alternative with prosthesis implant and left ventricular restoration. Eur J Cardiothorac Surg 2006; 29 (suppl 1):S266-S271.
132. Bacal F, Silva CP, Bocchi EA et al. Mycophenolate mofetil increased chagas disease reactivation in heart transplanted patients: comparison between two different protocols. Am J Transplant 2005; 58: 2017-21.
133. Bocchi EA, Fiorelli A. The paradox of survival results after heart transplantation for cardiomyopathy caused by Trypanosoma cruzi. First Guidelines Group for Heart Transplantation of the Brazilian Society of Cardiology. Ann Thorac Surg 2001; 716: 1833-8.
134. Soares MB, Lima RS, Rocha LL et al. Transplanted bone marrow cells repair heart tissue and reduce myocarditis in chronic chagasic mice. Am J Pathol 2004; 1642: 441-7.
135. Guarita-Souza LC, Carvalho KA, Woitowicz V et al. Simultaneous autologous transplantation of cocultured mesenchymal stem cells and skeletal myoblasts improves ventricular function in a murine model of Chagas disease. Circulation 2006; 1141 (suppl):I120-I124.
136. Vilas-Boas F, Feitosa GS, Soares MB et al. [Early results of bone marrow cell transplantation to the myocardium of patients with heart failure due to Chagas disease]. Arq Bras Cardiol 2006; 872: 159-66.
137. Tura BR, Martino HF, Gowdak LH et al. Multicenter randomized trial of cell therapy in cardiopathies-MiHeart Study. Trials 2007; 8: 2.
138. Oliveira-Filho J, Viana LC, Vieira-de-Melo RM et al. Chagas disease is an independent risk factor for stroke: baseline characteristics of a Chagas Disease cohort. Stroke 2005; 369: 2015-17.
139. Sousa AS. Incidencia e escores de risco de acidente vascular encefalico cardioembolico em uma Coorte de 1043 pacientes com doencas de chagas: avaliacao do prognostico e proposta de estrategias de prevencao. Hospital Universitario Clementino Fraga Filho, doctoral thesis, 2003.
140. de Sousa AS, Xavier SS, de Freitas GR, Hasslocher-Moreno A. Prevention strategies of cardioembolic ischemic stroke in Chagas' disease. Arq Bras Cardiol 2008; 91 (5): 306-10.